Randomized, Double Blinded, Placebo Control Clinical Trial of Pandemic Influenza Inactive Vaccine on Healthy Subjects
|ClinicalTrials.gov Identifier: NCT00356798|
Recruitment Status : Completed
First Posted : July 26, 2006
Last Update Posted : November 9, 2007
|Condition or disease||Intervention/treatment||Phase|
|Influenza||Biological: an inactivated whole virion H5N1 vaccine, adjuvanted||Phase 1|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||120 participants|
|Intervention Model:||Factorial Assignment|
|Official Title:||The Phase-I Clinical Trial Protocol for the Pandemic Inactivated Influenza Vaccine|
|Study Start Date :||December 2005|
|Estimated Study Completion Date :||April 2006|
- To evaluate the safety of pandemic inactivated influenza vaccine by different does.
- To evaluate the immunogenicity of pandemic inactivated influenza vaccine by different does.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00356798
|China-Japan Friendship Hospital|
|Beijing, Beijing, China, 100029|
|Principal Investigator:||Jiangtao Lin, MD||China-Japan Friendship Hospital|